Insights from exome sequencing for endocrine disorders.

Area of Science:

• Genomics
• Endocrinology
• Human Genetics

Background:

• Whole-exome sequencing (WES) is a key technology for identifying genetic causes of diseases.
• Decreasing costs and increasing availability of next-generation sequencing (NGS) facilitate large-scale genetic studies.
• WES is increasingly applied to both rare and common human diseases.

Purpose of the Study:

• To review recent advancements in endocrinology driven by exome sequencing.
• To discuss the impact of WES on understanding endocrine disorders.
• To explore the future role of WES in endocrine research and clinical practice.

Main Methods:

• Review of current literature on exome sequencing applications in endocrinology.
• Analysis of WES-driven discoveries in adrenal disease, growth and puberty disorders, and type 2 diabetes mellitus.
• Synthesis of findings related to rare genetic syndromes with endocrine involvement.

Main Results:

• Exome sequencing has significantly advanced the understanding of numerous endocrine disorders.
• Key genetic defects underlying adrenal diseases, growth/puberty disorders, and type 2 diabetes have been elucidated.
• WES has identified novel genetic causes for rare syndromes with endocrine manifestations.

Conclusions:

• Whole-exome sequencing is a transformative tool in endocrinology.
• Its application in research and clinical settings is expected to expand, leading to further breakthroughs.
• WES will play a crucial role in personalized endocrine medicine and disease management.